Clinical trial
Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study
NCT02789176 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study
- Lead sponsor
- University of Michigan
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2016
- Completion date
- March 24, 2020
- Enrollment
- 303 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
neonatal seizures